<p>iSpecimen Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission. The filing lists Lee Arphing as a Director and reports that no securities are currently beneficially owned. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. iSpecimen Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002097334-25-000002), on November 19, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

ISPC

<p>iSpecimen Inc. has filed an initial statement of beneficial ownership with the U.S. Securities and Exchange Commission, listing Lee Arphing as a Director with no securities currently beneficially owned. The filing can be accessed via EDGAR. This news brief was created by Public Technologies using AI and is for informational purposes only.</p>

iSpecimen Inc. Files Initial Statement of Beneficial Ownership for Director Lee Arphing